Senior Director, Global Market Access- Oncology Thoracic Antibodies and ADCs

New Jersey, US; Berlin, Germany; Cambridge, US; London, United Kingdom; Mainz, Germany; Munich, Germany | full time | Job ID:9446

Position Summary

The newly created position of Senior Director, Global Market Access- Oncology Thoracic Antibodies and Antibody Drug Conjugates (ADCs), will lead BioNTech’s global market access and support pricing strategies for our Antibody and ADC platforms both entering and in registrational phase trials across all thoracic tumor types, including but not limited to NSCLC, SCLC, H&N, GBM and Mesothelioma. In this position, you will play a key role in advancing BioNTech’s mission as part of the Global Value, Access, Pricing & Policy (GVAPP) team.

This position can be filled in the US (Eastern Coast), UK (London), Germany (Mainz, Munich or Berlin).

The role will serve as the global market access strategy lead for thoracic indications for BNT327/PM8002, BioNTech’s PD-L1 x VEGF bispecific antibody, as well as ADCs and novel-novel combinations. The Senior Director will oversee a small team of direct reports focused on specific thoracic tumors, indications, and combinations, while ensuring alignment and optimization of product market access and pricing across indications within alliances and partnerships.

The role will be responsible for defining pricing and access requirements and influencing clinical development, medical, and HEOR evidence generation strategies to deliver robust and compelling value evidence packages to optimize patient access to thoracic indications for our antibody and ADC medicines at prices reflective of their holistic value to patients, caregivers, the healthcare system and society. Additionally, the position will collaborate closely with access policy, pricing, and public affairs teams to develop innovative policy and environment-shaping strategies, ensuring appropriate HTA valuation, access, and reimbursement for thoracic indications for our antibodies and ADCs, including novel-novel combinations, as part of a potentially curative in-house approach to cancer.

• Lead the development of BioNTech’s market access strategies for antibodies, ADCs, and novel-novel combinations across the product lifecycle for thoracic tumor types, including (but not limited to) NSCLC, SCLC, HNSCC, GBM, and Mesothelioma
• Collaborate with Global Pricing Leads, Policy and HEOR colleagues to contribute to integrated Global Value, Access, Pricing & Policy (GVAPP) strategies
• Provide key insights on market access, pricing and policy to cross-functional teams including alliance teams, clinical development, and corporate strategy, ensuring a holistic patient-centric access approach from the outset into the evolving clinical development programs
• Review commercialization strategies and identify opportunities from an access, pricing and policy perspective and run Global Market Access research projects and lead value and access assessments to inform financial forecasting, business development, and strategy development
• Develop and lead fully integrated access strategies by aligning market access, pricing, HEOR, evidence planning, payer value communication, and stakeholder management plans
• Develop payer value propositions and supporting resources that reflect the holistic value of BioNTech’s innovations and enable early evidence and stakeholder engagement planning
• Partner with Pricing Leads, Regulatory, and Commercial to optimize indication and geographic launch sequencing optimization plans by conducting comprehensive market access landscape assessments, early scientific advisory meetings, and development of reimbursement strategies
• Educate internal stakeholders, business leaders, and affiliates on existing or future access and reimbursement risks and opportunities for oncology assets in a dynamic healthcare system by seeking broad input and feedback to inform oncology portfolio strategies and priorities
• Support innovative pricing, reimbursement and contracting solutions to overcome pricing and reimbursement challenges with a particular focus on novel-novel combination therapies
• Support Global Pricing policies, governance structures, and successful execution of Global Pricing strategies by informing clinical development plans, trial designs, and SKU strategies
• Anticipate global market access and pricing trends and regulations, monitor competitor activities, identify strategic implications for BioNTech, and educate internal colleagues and senior business leaders on the global market access and pricing environment
• Leverage knowledge of the external policy and decision-maker environment to optimize evidence development and identify and highlight differentiation for our oncology portfolio in close collaboration with Policy colleagues to identify systemic challenges to optimal pricing & reimbursement, and propose policy-based solutions
• Plan, manage, and track consultants, agencies, vendor partnerships, and budget requirements, ensuring cost-effective execution of key activities within established timelines and budget constraints

• Minimum of 10+ years of experience in global market access and pricing within pharmaceutical/biotech companies and/or consulting, with proven launch experience and a track record of developing and executing successful integrated access strategies
• Bachelor’s degree required; post-graduate degree preferred in a relevant field such as (Health) Economics, Health Policy, Health Systems, Healthcare Administration, Pharmacy, Biotechnology, or an MBA
• Extensive experience in creating global market access strategies that optimize patient access to immuno-oncology medicines (e.g., PD-(L)1 therapies) at prices reflective of their holistic value, including life-cycle management across multiple indications and combinations
• Deep knowledge of global pricing, health technology assessment (HTA), clinical development, payer organization methods and processes, with experience in how to successfully navigate complex systems worldwide
• Established network of relationships with key stakeholders and organizations that influence value assessment and reimbursement decisions
• Experience engaging HTA and payer organizations in early scientific advice to inform clinical development strategies and trial designs
• In addition to extensive global market access and pricing expertise, regional and/or country-level experience is preferred, including knowledge of new EU HTA centralization methods and processes
• Demonstrated experience in building and enhancing market access and pricing strategy capabilities
• Motivated contributor with hands-on experience implementing successful market access strategies, strong team player with exceptional partnering, communication, and interpersonal skills
• Strategic, analytical, and negotiation skills, with a deep understanding of HTA processes and requirements in a dynamic global environment
• Proven leadership and team management skills, with experience collaborating across matrix teams and mentoring global market access and pricing professionals to drive performance and achieve business objectives
• Excellent verbal and written communication skills in English; proficiency in a second language is appreciated

BioNTech US is committed to employee wellbeing and offers best-in-class benefits & HR programs to support an inclusive & diverse workforce. Salaried/Position-Targeted Hourly Employees working 30+ hours per week are eligible for our comprehensive benefits package. Benefits include but are not limited to:

• Medical, Dental and Vision Insurance
• Life, AD&D, Critical Illness Insurance
• Pre-tax HSA & FSA, DCRA Spending Accounts
• Employee Assistance & Concierge Program (EAP) available 24/7
• Parental and Childbirth Leave & Family Planning Assistance
• Parental and Childbirth Leave & Family Planning Assistance
• Sitterstream: Virtual Tutoring & Childcare Membership
• Paid Time Off: Vacation, Sick, Bereavement, Holidays (including Floating) & Year-End U.S. Shutdown.
• 401(K) Plan with Company Match
• Tuition Reimbursement & Student Loan Assistance Programs
• Wellbeing Incentive Platforms & Incentives
• Professional Development Programs
• Commuting Allowance and subsidized parking
• Discounted Home, Auto & Pet Insurance

…and more! More details to be shared.

Berkeley Heights is New Jersey's growing hub within the life sciences industry and has already demonstrated the state’s commitment to innovation, collaboration, and excellence within the field. New Jersey's integrated approach to biotechnology and pharmaceuticals harmonizes academic rigor, industrial capability, and government support to create thriving conditions for a growing ecosystem. Cultivating an environment that seamlessly integrates cutting-edge research, robust manufacturing capabilities, and a dynamic business landscape, New Jersey has become a powerhouse in pharmaceuticals, biotechnology, and medical technology. As this region of New Jersey continues to develop, it stands ready to shape the future of medical science and technology, driving progress and improving health outcomes worldwide.